Evidence map›Paper›PMID 37171793›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

m

Xia Yang, Qiaorui Bai, Weizhong Chen, Jiaer Liang, Fang Wang, Weiqi Gu, Lei Liu, Quanfeng Li, Zishuo Chen, Anni Zhou and 8 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. IGF2BP3 recognizes mThe EMBO journal · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Xia YangAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.ORCID 0000-0001-9029-3553
Qiaorui BaiAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Weizhong ChenDepartment of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Jiaer LiangAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Fang WangAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Weiqi GuAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Lei LiuChongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Quanfeng LiDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 518033, China.
Zishuo ChenCancer Institute, Southern Medical University, Shenzhen, 510515, China.
Anni ZhouDepartment of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Jianting LongDepartment of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Han TianAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Jueheng WuAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Xiaofan DingFaculty of Health Sciences Building University of Macau, Macau, 999078, China.
Ningning ZhouDepartment of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Mengfeng LiAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Yi YangDepartment of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.ORCID 0000-0001-9898-0366
Junchao CaiAdvanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.ORCID 0000-0001-8412-6177
Sun Yat-sen University · CNSouthern Medical University Shenzhen Hospital · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CNUniversity of Macau · MO

Funding

Guangdong Basic and Applied Basic Research Foundation 2020A1515010130Guangdong Basic and Applied Basic Research Foundation 2023A1515010378National Natural Science Foundation of China 81572837National Natural Science Foundation of China 81820108025National Natural Science Foundation of China 81922050National Natural Science Foundation of China 81972730National Natural Science Foundation of China 82030088National Natural Science Foundation of China 82241231
6 · The paper itself

Abstract

The importance of mRNA N6-methyladenosine (m

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsAdenosineCell Cycle ProteinsHumansRNA-Binding ProteinsRNA, MessengerAdenosineCell Cycle ProteinsIGF2BP3 protein, humanMCM5 protein, humanRNA-Binding ProteinsRNA, Messengerlung adenocarcinomam6A modificationMCM5Notch signalingpartial EMT

Identifiers

PMID37171793
PMCPMC10369244
OpenAlexW4376224019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.